Table 1.
Rapid virologic response (RVR) | Qualitative HCV RNA assay done at 4 weeks comes out to be negative (<50 lU/mL) |
Early virologic response (EVR) | Quantitative HCV RNA assay done at 12 weeks: |
Comes out to be negative — called early virologic clearance (EVC) or aviremic response | |
Shows a decline in the HCV RNA titer (compared with the pretreatment assay) of ≥ 2 log — called partial virologic response (PVR) or viremic response | |
Nonresponders | Quantitative HCV RNA assay done at 12 weeks showing either no decline in the HCV RNA titer (compared with the pretreatment assay) or a decline of < 2 log |
End-of-treatment response (ETR) | Qualitative HCV RNA assay done on completion of the recommended duration of the course comes out to be negative |
Sustained virologic response (SVR)* | Qualitative HCV RNA assay done 24 weeks after completion of the recommended duration of the course comes out to be negative |
Relapsers | Qualitative HCV RNA assay done on completion of the recommended duration of the course is negative; but 24 weeks later, the assay done to confirm SVR comes out to be positive |
Achievement of SVR is generally considered as the marker of eradication of HCV infection. Almost all such patients show EVC or PVR on 12-week assay